# OnCo record linker-mm1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/linker-mm1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "linker-mm1", "NCT03761108" ;
  schema:name "LINKER-MM1"@en ;
  schema:description "LINKER-MM1 is the pivotal study for linvoseltamab, with 45% complete responses."@en ;
  schema:url <https://onco.cc/trials/linker-mm1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03761108> ;
  onco:status "positive" ;
  onco:phase "1/2" ;
  schema:startDate "2019-01-23" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/linvoseltamab/> ;
  onco:companies <https://onco.cc/companies/regeneron/> .